Percutaneous radiofrequency ablation for hepatocellular carcinoma

By R. Tateishi, S. Shiina, T. Teratani, S. Obi, Shin'pei Sato, Y. Koike, T. Fujishima, H. Yoshida, T. Kawabe, M. Omata. Cancer, 2005

695 citations recorded by the source corpus.

Radiofrequency ablation (RFA) was introduced recently as a therapeutic modality for hepatocellular carcinoma (HCC), an alternative to percutaneous ethanol injection therapy (PEIT), which is coming into use worldwide. Previously reported treatment efficacy and complication rates have varied considerably.

Subfields: Epidemiology, Hepatology, Surgery

View Paper: https://www.semanticscholar.org/paper/d24b354a977f42300564312774cce704844ce47f